Strategic Partnerships BioFlyte has formal collaboration activity with Los Alamos National Laboratory, indicating openness to joint modeling, simulation, and validation work. This can translate into co-developed solutions or pilot programs with defense and national lab customers.

SBIR Driven Opportunities Recent SBIR Phase II with the U.S. Air Force and Phase I with AFWERX signal strong government funding momentum for BioTOF z200 and related threat monitoring tech, suggesting prioritizing defense and critical infrastructure clients seeking SBIR-aligned procurement and integration.

Defense and Infrastructure Focus Active engagement with military and critical infrastructure players (Air Force contract, AFWERX involvement, Pittsburgh International Airport pilot) highlights a clear path for expanding sales to airports, federal facilities, and other mission-critical sites requiring rapid threat detection and screening.

Early Warning Advantage BioFlyte’s BioTOF z200 enables dynamic threat monitoring with early warning, analysis, and confirmation across chemical and biological threats, presenting a compelling value proposition for customers needing continuous monitoring, rapid decision support, and scalable field deployment.

Compact, Fieldable Solutions With a small team and revenue in the low millions, BioFlyte’s fieldable, scalable platforms appeal to agencies and contractors seeking deployable surveillance tech for rapid deployment in diverse environments, including airports and defense sites.